Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bio-Rad Labs Inc. A buy Royal Bank of Canada

Start price
€297.10
17:30 / 50%
Target price
€364.63
16.08.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 16.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time.
Performance without dividends (%)
Name 1w
Bio-Rad Labs Inc. A -
iShares Core DAX® 2.821%
iShares Nasdaq 100 5.285%
iShares Nikkei 225® 3.687%
iShares S&P 500 3.577%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Bio-Rad Labs Inc. A diskutieren
Prediction Buy
Perf. (%) -
Target price 364.629
Change
Ends at 16.08.25

Bio-Rad Laboratories, Inc. (NYSE: BIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $401.00 price target on the stock.
Ratings data for BIO provided by MarketBeat

Stopped prediction by Royal_Bank_of_Canada for Bio-Rad Labs Inc. A

buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€307.80
02.08.24
€367.36
02.08.25
-3.48%
15.08.24

buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€316.20
16.02.24
€445.58
16.02.25
-6.04%
15.08.24

buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€363.40
04.08.23
€474.64
04.08.24
-17.06%
05.08.24